ETS-targeted therapy: can it substitute for MEK inhibitors?

por Tetsu, Osamu, McCormick, Frank
Publicado 2017

Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2

por Phuchareon, Janyaporn, Ohta, Yoshihito, Woo, Jonathan M., Eisele, David W., Tetsu, Osamu
Publicado 2009

A Critical Role for FBXW8 and MAPK in Cyclin D1 Degradation and Cancer Cell Proliferation

por Okabe, Hiroshi, Lee, Sang-Hyun, Phuchareon, Janyaporn, Albertson, Donna G., McCormick, Frank, Tetsu, Osamu
Publicado 2006

c-Kit Expression is Rate-Limiting for Stem Cell Factor-Mediated Disease Progression in Adenoid Cystic Carcinoma of the Salivary Glands()()

por Phuchareon, Janyaporn, van Zante, Annemieke, Overdevest, Jonathan B., McCormick, Frank, Eisele, David W., Tetsu, Osamu
Publicado 2014

Fatty Acid Binding Protein 7 Is a Molecular Marker in Adenoid Cystic Carcinoma of the Salivary Glands: Implications for Clinical Significance()()

por Phuchareon, Janyaporn, Overdevest, Jonathan B., McCormick, Frank, Eisele, David W., van Zante, Annemieke, Tetsu, Osamu
Publicado 2014

Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells

por You, Bin, Yang, Yi-Lin, Xu, Zhidong, Dai, Yuyuan, Liu, Shu, Mao, Jian-Hua, Tetsu, Osamu, Li, Hui, Jablons, David M., You, Liang
Publicado 2015